Related Experiment Video
Updated: Dec 13, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Urinary biomarkers in lupus nephritis
Cristian C Aragón1, Raúl-Alejandro Tafúr1,2, Ana Suárez-Avellaneda1
1GIRAT: Grupo de Investigación en Reumatología, Autoinmunidad y Medicina Traslacional, Fundación Valle Del Lili and Universidad Icesi, Cali, Colombia.
Urinary biomarkers show promise for monitoring lupus nephritis (LN), a kidney complication of systemic lupus erythematosus (SLE). These markers may help predict disease flares and treatment response, offering an alternative to invasive kidney biopsies.
Area of Science:
- Nephrology
- Immunology
- Autoimmune Diseases
Background:
- Systemic lupus erythematosus (SLE) is a multi-organ autoimmune disease.
- Lupus nephritis (LN), kidney inflammation in SLE patients, affects 30-70% of cases.
- Kidney biopsy is the standard for LN classification but has limitations in predicting treatment response and monitoring disease activity.
Purpose of the Study:
- To review advances in urinary biomarkers for lupus nephritis.
- To highlight the potential of these biomarkers in early detection of sub-clinical flares and monitoring therapeutic response.
- To discuss the role of certain biomarkers in the pathogenesis of LN.
Main Methods:
- Review of current literature on lupus nephritis urinary biomarkers.
- Analysis of conventional and non-conventional urinary markers.
- Correlation of biomarker findings with histological LN classifications.
Main Results:
- Various conventional biomarkers (e.g., proteinuria) and non-conventional biomarkers (e.g., MCP-1) are studied for LN.
- Urinary biomarkers offer a less invasive approach compared to serial kidney biopsies.
- Some biomarkers are implicated in the underlying mechanisms of lupus nephritis.
Conclusions:
- Urinary biomarkers are valuable tools for complementing traditional methods in LN management.
- Future research should focus on validating these markers for early flare prediction and therapy monitoring.
- Understanding biomarker involvement in LN pathogenesis may lead to targeted therapies.
Related Concept Videos
Serum Studies: Renal Function Tests
Nephrotic Syndrome II : Assessment and Medical Management
Urine Studies I: Urinalysis
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

